Literature DB >> 9715876

NETCORD: a cord blood allocation network.

P Hakenberg1, G Kögler, P Wernet.   

Abstract

Several CB-specific prerequisites have to be taken into consideration to deal with the increasing number of stem cell transplants using multiple HLA mismatched umbilical cord blood (CB) specimens. Since CB represents a limited and expensive resource it demands an optimal allocation. Optimal CB allocation can not be optimal based solely on 'first come - first serve' basis, since frequently several CB specimens are simultaneously suitable for more than one patient. Furthermore, the immediate availability of CB gives rise to an above average proportion of urgent search requests for patients who need a transplantation urgently. Thus continuing reservation and release of a CB specimen has considerable influence on the stem cell transplant prospects of other patients. To avoid and/or solve allocation conflicts present in a much higher incidence than in the bone marrow donor setting a global co-ordinated allocation of cord blood specimens is of major advantage for these patients. Therefore, the CB allocation network NETCORD has been founded. Within NETCORD common rules for data representation and logistics were developed to make CB data comparable and interchangeable. The extended need for fast and reliable communication is met by modern communication technology based on Internet standards.

Entities:  

Mesh:

Year:  1998        PMID: 9715876

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  2 in total

Review 1.  Family-directed umbilical cord blood banking.

Authors:  Eliane Gluckman; Annalisa Ruggeri; Vanderson Rocha; Etienne Baudoux; Michael Boo; Joanne Kurtzberg; Kathy Welte; Cristina Navarrete; Suzanna M van Walraven
Journal:  Haematologica       Date:  2011-07-12       Impact factor: 9.941

Review 2.  Concise review: umbilical cord blood transplantation: past, present, and future.

Authors:  Javier Munoz; Nina Shah; Katayoun Rezvani; Chitra Hosing; Catherine M Bollard; Betul Oran; Amanda Olson; Uday Popat; Jeffrey Molldrem; Ian K McNiece; Elizabeth J Shpall
Journal:  Stem Cells Transl Med       Date:  2014-11-05       Impact factor: 6.940

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.